In the media 29 Apr 2026 Thailand approves ravidasvir, a new drug for hepatitis C, increasing chances of complete cure Thai Rath
Scientific articles 30 Apr 2026 Overcoming Trypanosoma cruzi persistence with a mechanistically distinct drug combination npj Antimicrobials and Resistance
In the media 29 Apr 2026 ไทยรับรอง “ราวิดาสเวียร์” ยาใหม่รักษาไวรัสตับอักเสบซี เพิ่มโอกาสรักษาหายขาด Thai Rath
Press releases 27 Apr 2026 Thailand registers ravidasvir, a simple-to-use and effective antiviral for hepatitis C, expanding treatment options for Thai patients
In the media 25 Apr 2026 ‘Estamos na fase de eliminação’: RD Congo avança no combate à doença que matou milhões na África Alma Preta
In the media 24 Apr 2026 Dengue treatments in 2-3 years, but cases set to rise with climate change Times of India
In the media 23 Apr 2026 India eyes dengue treatment rollout within five years as vaccine pipeline advances The New Indian Express
In the media 26 Mar 2026 Un golpe de efecto para acabar con la enfermedad del sueño: “Aspiramos a eliminar el trastorno en 2030” El Mundo
Stories Lab lessons that matter: Pharmacy students help bridge the gap in research for neglected diseases
Scientific articles 14 Apr 2026 Translational Pharmacokinetic-Pharmacodynamic Modeling and Efficacious Human Dose Prediction of DNDI-6148 for the Treatment of Cutaneous Leishmaniasis Clinical and Translational Science
In the media 11 Apr 2026 Face à la dengue, la recherche s’active alors que le réchauffement laisse craindre une saison 2026 record Le Monde
Scientific articles 27 Mar 2026 Prognostic models predicting clinical outcomes in patients diagnosed with visceral leishmaniasis: a systematic review BMJ Public Health
Press releases 27 Apr 2026 Thailand registers ravidasvir, a simple-to-use and effective antiviral for hepatitis C, expanding treatment options for Thai patients
Press releases 4 Mar 2026 Pandemic preparedness: Novo Nordisk Foundation renews its support to DNDi and THSTI to continue the development of broad-spectrum antivirals
Press releases 27 Feb 2026 Acoziborole Winthrop, developed by DNDi and Sanofi, receives European Medicines Agency positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness
Press releases 10 Feb 2026 DNDi and Dubai Health launch Middle East partnership to advance research and training in neglected diseases
Press releases 27 Nov 2025 International seminar explores the development of treatments for dengue for populations not covered by vaccines
Press releases 10 Nov 2025 COP 30: The climate crisis is also a crisis for neglected diseases, warns DNDi
Press releases 4 Nov 2025 European Commission invests EUR 20 million to develop urgently-needed medicines against dengue in partnership with AFD and DNDi
Press releases 23 Sep 2025 Open-science approach delivers a promising pre-clinical candidate for broad-spectrum coronavirus antiviral
Press releases 15 Sep 2025 Switzerland renews commitment to DNDi to advance medical innovation for neglected patients
Press releases 22 Aug 2025 DNDi receives Japan’s Hideyo Noguchi Africa Prize 2025 for its work to develop new treatments for neglected diseases in Africa
Press releases 23 Jul 2025 AN2 Therapeutics and DNDi collaborate on clinical development of promising new oral compound to treat chronic Chagas disease
Press releases 10 Jul 2025 New HIV project in the DRC brings life-saving care closer to people with advanced HIV disease
Press releases 1 Jul 2025 Thailand’s Government Pharmaceutical Organization (GPO) partners with DNDi and Pharco to register an effective and affordable hepatitis C treatment
Press releases 13 Jun 2025 K-MEDI and DNDi have initiated collaborative R&D to develop a treatment for neglected diseases
Press releases 13 Jun 2025 Serum Institute of India signs a memorandum of understanding (MoU) with DNDi to advance the development of a new treatment for dengue in low- and middle-income countries
Press releases 5 Jun 2025 Colombia becomes first country to recommend rapid tests to diagnose Chagas disease